Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-04

FDA Approved: TERIFLUNOMIDE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's original application for a generic teriflunomide, expanding access to this disease-modifying therapy for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

ORIG AP for TERIFLUNOMIDE (TERIFLUNOMIDE)